mail
kjamrvpsv@gmail.com
whatsapp
+919447535633
e-ISSN: 3107-4057

Kottakkal Journal of Ayurvedic Medicine And Research

Published

AYURVEDIC MANAGEMENT OF ACHARANA YONIVYAPATH WITH PRAMEHA

Published in October-December 2025 (Vol. 1, Issue 4, 2025)

AYURVEDIC MANAGEMENT OF ACHARANA YONIVYAPATH WITH PRAMEHA - Issue cover

Abstract

Introduction: Yoni Kandu (vaginal itching) and Pichila Srava (thick vaginal discharge) are frequently encountered gynecological complaints, often associated with Prameha in Ayurveda. Long standing Prameha often gives rise to several Upadravas (complications), among which Yoni Kandu is significant due to its impact on quality of life. The condition is aggravated by Kapha and Vata doshas and Dhatu Dushti, particularly of Rasa and Rakta. This case explores the Ayurvedic management of Yoni Kandu in Acharana Yonivyapath in a Type 1 diabetic female patient. Methods: A 28-year-old female, with Type 1 Diabetes Mellitus, presenting with 10-year history of vaginal itching and white discharge was treated with classical Ayurvedic regimen. The treatment focused on Deepana-Pachana (enhancing digestion and metabolism), Kapha-Vata Shamana (pacifying aggravated doshas), and Yoni Shodhana (cleansing of the vaginal tract). Internal medications included Chandraprabha Vati, Triphala Guggulu, Nimbashatka churna and Nishamalaki Churna. Local therapy included Yoni Prakshalana with Triphala Kashaya and application of Nimbamalahara Lepa. Dietary and lifestyle modifications were advised, along with monitoring of blood sugar levels. Results: The patient reported significant relief in symptoms within four weeks of treatment. Itching reduced substantially, discharge became minimal and non-offensive, and the patient experienced improved local comfort (in vulvar region). No adverse effects were reported. Blood glucose levels reduced drastically during the treatment period, indicating compatibility of Ayurvedic treatment with ongoing insulin therapy. Discussion: This case demonstrates the potential of Ayurvedic intervention in managing Yoni Kandu due to Acharana yonivyapath and Prameha Upadrava. By addressing Dosha imbalance and supporting metabolic health, the treatment led to symptomatic relief and improved patient well-being. Integrative management with regular monitoring can provide a holistic approach for such chronic complications in diabetic individuals. Conclusion: Ayurvedic management offers an effective and safe approach to Prameha-related Yoni Kandu. The case supports the role of dosha-specific, individualized therapy in chronic gynecological conditions associated with metabolic disorders like Type 1 Diabetes Mellitus. Further clinical studies are recommended to validate these findings.

Authors (2)

Gopika P

PG Scholar, Dept of Prasuti Tantra and Stree Roga, Sri Sri College of Ayurvedic Science and Research, Bengaluru – 560082, Karnataka, India

View all publications →

Rachana H.V

Professor, Dept of Prasuti Tantra and Stree Roga, Sri Sri College of Ayurvedic Science and Research, Bengaluru – 560082, Karnataka, India

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

Article ID:
KJAMR-00000049
Paper ID:
KJAMR-01-000049

How to Cite

P & H.V (2025). AYURVEDIC MANAGEMENT OF ACHARANA YONIVYAPATH WITH PRAMEHA. Kottakkal Journal of Ayurvedic Medicine And Research, 1(4), xx-xx. https://kjamr.scholarjms.com/articles/23

Article Actions

Article Impact

Views:3,082
Downloads:1,316
3,082
Article Views
1,316
Downloads
109
Citations
24
Social Shares

More from this Issue

A CROSS-SECTIONAL STUDY TO ASSESS KNOWLEDGE, ATTITUDE AND PRACTICE OF ANAGNI SWEDA AMONG AYURVEDA PRACTITIONERS OF KERALA

Anagni Swedana is a non-fire-based Ayurvedic sudation therapy used for relaxation, pain relief, and restoring balance according to dosha, disease and patient strength. Methods: A three-phase study was conducted. First, classical Ayurvedic texts were reviewed to identify descriptions of Swedana and Anagni Swedana. Next, the techniques were critically analyzed and classified into eight domains. Finally, a validated questionnaire survey was conducted among 104 senior Ayurveda practitioners in Kerala to assess their knowledge, attitude, and practice about Anagni sweda. Results: The review established both similarities and discrepancies in textual descriptions of Anagni Swedana. Practitioners demonstrated strong theoretical understanding but varied in actual clinical use. The survey highlighted inconsistencies in application regarding dosha, disease strength, patient condition and other contextual factors.

Swethadas V P, Dr.Vinod D S, Dr Neenu Jessy SabuRead more →

ASSESSMENT OF HMG-CO ENZYME A REDUCTASE INHIBITING ACTIVITY OF CHLOROGENIC ACID AND GALLIC ACID, PHENOLIC COMPOUNDS PRESENT IN THE LEAF OF AZADIRACHTA INDICA A JUSS. THROUGH MOLECULAR DOCKING

Background: Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, with dysregulation of cholesterol metabolism as a key contributor. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) is the rate-limiting enzyme in cholesterol biosynthesis, targeted effectively by statins. However, statins can cause adverse effects, highlighting the need for safer, natural alternatives. Gallic acid and chlorogenic acid, abundant phenolic compounds in Azadirachta indica leaves, have shown potential HMGR inhibitory activity. The objective was to evaluate the HMGR inhibitory potential of gallic acid and chlorogenic acid through molecular docking analysis, thereby elucidating their possible role as natural lipid-lowering agents. Methods: Molecular docking was performed using AutoDock Vina across seven potential binding sites of HMGR, identified from crystal structure analysis. Ligand structures were prepared from PubChem, and receptor refinement was conducted in BIOVIA Discovery Studio. Binding affinities and ligand–protein interactions were analyzed to assess inhibitory potential. Results: Binding energies for gallic acid ranged from –3.7 to –6.0 kcal/mol, with strongest binding at Site 5 (–6.0 kcal/mol), primarily stabilized by hydrophobic (Pi–Sigma, Pi–Alkyl) and electrostatic interactions (Pi–Anion, Pi–Cation). Chlorogenic acid exhibited higher binding affinities across sites (–4.3 to –7.3 kcal/mol), with Sites 5 (–7.2 kcal/mol) and 7 (–7.3 kcal/mol) showing the strongest interactions, dominated by hydrophobic alkyl–alkyl contacts. Overall, chlorogenic acid demonstrated stronger site-specific binding than gallic acid, though both showed weaker binding compared to statins. Discussion & Conclusion: Chlorogenic acid exhibits greater affinity for HMGR than gallic acid, suggesting its potential as a moderate natural HMGR inhibitor. These findings warrant further in vitro and in vivo studies to validate their cholesterol-lowering potential and explore their use as safer alternatives or adjuncts to statin therapy.

Gopika Mahesh, Dr.Vivek PRead more →

NEUROLOGICAL ACTIVITIES OF TAGARA (VALERIANA JATAMANSI JONES EX ROXB.)

Background: Valeriana jatamansi Jones (Family: Valerianaceae), a high value medicinal plant, is distributed in many countries of Asia. The species has been widely utilized in both traditional and modern medicine, with V. jatamansi being particularly valued for its insect-repelling and anthelmintic properties. Similarly, indigenous systems of medicine, particularly in Asia, have reported neurological activities like neuroprotective, sedative, anxiolytic and neurodegenerative of the species in various ailments. This review highlights on the morphological characters, phytochemical composition, medicinal uses, and pharmacological activities of V. jatamansi along with compilation of neurological activities in various articles. Materials and methods: Journals, articles and various internet publications were referred to compile the relevant information of Tagara (Valeriana jatamansi Jones) and compilation of its various neurological activities. Result and discussion: A comprehensive review of existing literature reveals that V. jatamansi exhibits a broad spectrum of biological activities, including antimicrobial, antioxidant, anti-inflammatory, cytotoxic, antitumor, and neurologically beneficial effects such as neuroprotective, neurodegenerative, anxiolytic, antidepressant, and sedative properties. Even though there are reports about the pharmacological action of medicinal plant Tagara (Valeriana jatamansi Jones) in neurological diseases, more clinical based researches are required to substantiate their role in improving the well-being of the patient. Further investigation is necessary to fully understand the molecular mechanisms of V. jatamansi, and continued research efforts can potentially lead to the development of novel, evidence-based therapies for use in contemporary medicine.

Deepika V M, Dr.Vivek PRead more →
Whatsapp